Susan E. Barrowcliffe, General Manager, Europe at Aimmune Therapeutics, Inc. (AIMT), sold 40,000 shares at $30.04 ($1.2M) on 2018-11-19, disclosed to the SEC on 2018-11-21.
Open-market sale of $1.2M AIMT by General Manager, Europe. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AIMT | SELL | 2017-09-07 | $405K | — | Filing → |
| AIMT | SELL | 2017-07-31 | $11K | — | Filing → |
| AIMT | SELL | 2017-07-25 | $134K | — | Filing → |